Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Anna S Gerdtsson"'
Autor:
Karin Sundfeldt, Lavanya Lokhande, Anna S Gerdtsson, Sara Ek, Constantina Mateoiu, Asger M Frank, Elias Carlsson, Huaqiang Ouyang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/5dfbec4a607b4364a5754e27c2020ae4
Autor:
Joana Rodrigues, Lina Olsson, Daniel Nilsson, Lavanya Lokhande, May Hassan, Anna Porwit, Anna S Gerdtsson, Mats Jerkeman, Sara Ek
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/062c284851cf4dae849817b5577585e0
Autor:
James W. Hicks, Serena Zheng, Randolph Schaffer, Mariam Rodriguez-Lee, Jorge Nieva, Kelly Bethel, Jerry S.H. Lee, Jana-Aletta Thiele, Steven A. Curley, Stephanie N. Shishido, Heinz-Josef Lenz, Diana L. Hanna, Gerard J. Oakley, Anna S. Gerdtsson, Carmen Ruiz, Peter Kuhn, Anand Kolatkar
Publikováno v:
Oncotarget
As cancer care is transitioning to personalized therapies with necessary complementary or companion biomarkers there is significant interest in determining to what extent non-invasive liquid biopsies reflect the gold standard solid biopsy. We have es
Autor:
Mariam Rodriguez-Lee, Joe Larsen, Anders Carlsson, Anna S. Gerdtsson, Carmen Ruiz, Emily J. Greenspan, Sara Restrepo-Vassalli, Kelly Bethel, Peter Kuhn, Jorge Nieva, Liya Xu, Stephanie N. Shishido, Kathryn R. Waitman, Anand Kolatkar, Lisa Welter, James W. Hicks, E. Shelley Hwang
Publikováno v:
J Mol Diagn
Liquid biopsy allows assessment of multiple analytes, providing temporal information with potential for improving understanding of cancer evolution and clinical management of patients. Although liquid biopsies are intensely investigated for predictio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b17d2b106eff52c95e4607ca5d8120a
https://europepmc.org/articles/PMC7103765/
https://europepmc.org/articles/PMC7103765/
Publikováno v:
Future Science OA
Background: We introduce the combination of digital holographic microscopy (DHM) and antibody microarrays as a powerful tool to measure morphological changes in specifically antibody-captured cells. The aim of the study was to develop DHM for analysi
Autor:
Anna S. Gerdtsson, Malin Nordström, Carl A.K. Borrebaeck, Xin Wen, Payam Delfani, Christer Wingren, He Ren, Ulrika Ringdahl, Jihui Hao, Helena Persson
Pancreatic ductal adenocarcinoma (PDAC) is a disease where detection preceding clinical symptoms significantly increases the life expectancy of patients. In this study, a recombinant antibody microarray platform was used to analyze 213 Chinese plasma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e70244ec33d2d57731377a048fdd29f0
https://europepmc.org/articles/PMC5423191/
https://europepmc.org/articles/PMC5423191/
Autor:
Payam Delfani, Carl A.K. Borrebaeck, Erica Berglund, Linda Dexlin-Mellby, Anna S. Gerdtsson, Christer Wingren
Publikováno v:
Microarrays
Microarrays; Volume 5; Issue 2; Pages: 16
Microarrays, Vol 5, Iss 2, p 16 (2016)
Microarrays; Volume 5; Issue 2; Pages: 16
Microarrays, Vol 5, Iss 2, p 16 (2016)
Antibody microarrays have emerged as an important tool within proteomics, enabling multiplexed protein expression profiling in both health and disease. The design and performance of antibody microarrays and how they are processed are dependent on sev
Autor:
Jorge Nieva, Anna S. Gerdtsson, Mariam Rodriguez Lee, James W. Hicks, Diana L. Hanna, Peter Kuhn, Randolph Schaffer, Jana-Aletta Thiele, Heinz-Josef Lenz, Steven A. Curley, Kelly Bethel, Anand Kolatkar
Publikováno v:
Cancer Research. 78:4584-4584
Treatment of cancer patients is transitioning to personalized strategies using targeted drugs with the required companion biomarkers. Many current biomarkers are tissue-based, requiring a solid biopsy and limiting sampling frequency. Given this, ther
Autor:
Núria Malats, Francisco X. Real, Miquel Porta, Anna S. Gerdtsson, Petter Skoog, Helena Persson, Anna Säll, Carl A.K. Borrebaeck, Christer Wingren
Publikováno v:
International Journal of Proteomics
Recercat. Dipósit de la Recerca de Catalunya
instname
Recercat. Dipósit de la Recerca de Catalunya
instname
Background. Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with rapid tumor progression and poor prognosis. This study was motivated by the lack of sensitive and specific PDAC biomarkers and aimed to identify a diagnostic, serum pro